Litcius/Paper detail

Blood-Based Biomarkers for Predicting Immunotherapy Benefit in Lung Cancer

D. Ross Camidge, Erin L. Schenk

2020Cell11 citationsDOIOpen Access PDF

Topics & Concepts

ImmunotherapyLung cancerCancerOncologyChemotherapyTargeted therapyDiseaseBiologyPrecision medicineCancer immunotherapyInternal medicineMedicineCancer researchImmunologyPathologyCancer Immunotherapy and BiomarkersLung Cancer Research StudiesLung Cancer Treatments and Mutations
Blood-Based Biomarkers for Predicting Immunotherapy Benefit in Lung Cancer | Litcius